Strasbourg, France, April 7, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors during the upcoming editions of:
- Investor Access Event (by Allinvest Securities), on April 9, 2026, in Paris (France);
- Life Sciences Conference (by Van Lanschot Kempen), on April 16, 2026, in Amsterdam (Netherlands).
Next financial communications:
- April 29, 2026: First Quarter 2026 Financial Results
- May 22, 2026: Annual Shareholders’ Meeting
.../...
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer